The boom of copyright’s drug initially drove significant growth in the pharmaceutical sector, producing a perception of substantial profits. However, investing in companies heavily reliant on top-selling drugs like Viagra presents substantial dangers. Exclusive rights expiry has resulted in alter

The recent surge in funding into specialized pharmaceutical companies, particularly those focusing on experimental therapies and challenging drug development programs, has fueled what some are calling "High Roller Pharma." While the potential for blockbuster treatments and impressive returns is c